Thursday, 05 August 2021
  3 Replies
  724 Visits
Göttingen researchers have developed mini-antibodies that efficiently block the coronavirus SARS-CoV-2 and its dangerous new variants. These so-called nanobodies bind and neutralize the virus up to 1000 times better than previously developed mini-antibodies. In addition, the scientists optimized their mini-antibodies for stability and resistance to extreme heat. This unique combination makes them promising agents to treat COVID-19. Since nanobodies can be produced at low costs in large quantities, they could meet the global demand for COVID-19 therapeutics. The new nanobodies are currently in preparation for clinical trials.

Adam Thyer, Founder at GreenExecutive

1 year ago
This pandemic is a terrible thing. However, the upside is that it will dramatically accelerate the development of effective treatments for viruses and perhaps even other diseases such as cancer.
1 year ago
1. Status of WHO compliance/authorization for distribution?
2. Efficacy with one and two doses?
3. Global distribution plan?
4. Available through COVAX?
5. Efficacy for persons with compromised immune systems?
1 year ago
The New York Times has a "Coronavirus Drug and Treatment Tracker":

The Covid-19 pandemic is one of the greatest challenges modern medicine has ever faced. Doctors and scientists are scrambling to find treatments and drugs that can save the lives of infected people and perhaps even prevent them from getting sick in the first place.

Below is an updated list of 24 of the most-talked-about treatments for the coronavirus. While some are accumulating evidence that they’re effective, most are still at early stages of research. We also included a warning about a few that are just bunk.

Adam Thyer, Founder at GreenExecutive

  • Page :
  • 1
There are no replies made for this post yet.
Be one of the first to reply to this post!
© GreenExecutive. All rights reserved.